Pricing Log in Create free account
Saturday 17 October 2026 Export OPRX’s income statement to Excel — free account

OptimizeRx Corp.

OPRX Healthcare Health Information Services

OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

8.50 0.35 −3.95%
Market cap
$166.7M
P/E
35.4×
Fwd P/E
23.0×
Dividend yield
—
F-score
8/9
Altman Z
3.31
Beneish M
−2.77
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

OptimizeRx Corp. (OPRX) Business Profile

Updated before January 2025

Company Overview

OptimizeRx Corporation (NASDAQ: OPRX) is a leading digital health technology company that specializes in providing innovative solutions to improve communication and engagement between pharmaceutical companies, healthcare providers, and patients. Founded in 2006 and headquartered in Rochester, Michigan, OptimizeRx has grown to become a trusted partner in the healthcare industry, leveraging technology to streamline the delivery of critical information and resources.

The company was co-founded by David Harrell, who envisioned a platform that could bridge the gap between pharmaceutical companies and healthcare providers. Over the years, OptimizeRx has expanded its offerings and established itself as a leader in the digital health space. The company is currently led by Will Febbo, who serves as the Chief Executive Officer. Under his leadership, OptimizeRx has focused on innovation, strategic partnerships, and expanding its market presence.

Core Business Segments

OptimizeRx operates through several core business segments, each designed to address specific needs within the healthcare ecosystem. These segments include:

1. Digital Health Messaging

OptimizeRx’s flagship offering is its digital health messaging platform, which enables pharmaceutical companies to deliver targeted messages to healthcare providers at the point of care. This platform integrates seamlessly with electronic health record (EHR) systems, ensuring that healthcare providers receive timely and relevant information about medications, treatment options, and patient support programs.

2. Patient Support Services

The company provides a range of patient support services aimed at improving medication adherence and health outcomes. These services include co-pay assistance programs, medication reminders, and educational resources. By offering these tools, OptimizeRx helps patients overcome barriers to accessing and adhering to prescribed treatments.

3. Real-World Evidence and Analytics

OptimizeRx leverages its extensive data network to provide real-world evidence and analytics solutions. These offerings enable pharmaceutical companies to gain insights into prescribing patterns, treatment outcomes, and patient behavior. This data-driven approach helps optimize marketing strategies and improve patient care.

4. Telehealth Integration

Recognizing the growing importance of telehealth, OptimizeRx has developed solutions that integrate its messaging and support services into telehealth platforms. This ensures that healthcare providers and patients can access critical information and resources during virtual consultations.

Business Model

OptimizeRx operates on a business-to-business (B2B) model, primarily serving pharmaceutical companies, healthcare providers, and other stakeholders in the healthcare industry. The company generates revenue through:

  • Subscription Fees: Pharmaceutical companies pay subscription fees to access OptimizeRx’s digital health messaging platform and other services.
  • Transaction-Based Revenue: Revenue is also generated on a per-transaction basis for services such as co-pay assistance and patient support programs.
  • Data and Analytics Services: OptimizeRx monetizes its data and analytics capabilities by providing insights and reports to pharmaceutical companies and other clients.

The company’s business model is built on scalability and integration, allowing it to expand its offerings and reach new markets while maintaining strong relationships with existing clients.

Strategic Direction

OptimizeRx is focused on several strategic initiatives to drive future growth and innovation:

  • Expansion of Services: The company aims to expand its portfolio of digital health solutions, including enhanced patient support services and advanced analytics capabilities.
  • Global Market Penetration: OptimizeRx is exploring opportunities to enter new international markets, leveraging its expertise to address global healthcare challenges.
  • Sustainability Goals: The company is committed to sustainability and aims to reduce its environmental footprint by adopting eco-friendly practices and technologies.
  • Innovation in Telehealth: OptimizeRx plans to further integrate its solutions into telehealth platforms, ensuring that its services remain relevant in the evolving healthcare landscape.

Competitive Landscape

OptimizeRx operates in a competitive market, facing competition from both established players and emerging startups. Key competitors include:

  • Phreesia: A provider of patient intake and engagement solutions.
  • Healthgrades: A platform that connects patients with healthcare providers and offers marketing solutions for healthcare organizations.
  • Zocdoc: A digital health company that focuses on patient-provider matching and appointment scheduling.
  • GoodRx: A platform that helps patients find affordable medication options and discounts.

Despite the competition, OptimizeRx differentiates itself through its comprehensive suite of services, strong industry partnerships, and focus on innovation.

Risk Factors

OptimizeRx faces several risks that could impact its business operations and financial performance:

  • Market Dependence: The company relies heavily on pharmaceutical companies for revenue, making it vulnerable to changes in the pharmaceutical industry.
  • Regulatory Challenges: As a healthcare technology company, OptimizeRx must navigate complex regulatory environments, which could pose compliance risks.
  • Technological Disruptions: Rapid advancements in technology could render some of OptimizeRx’s solutions obsolete if the company fails to innovate.
  • Economic Uncertainty: Economic downturns and budget constraints in the healthcare sector could affect the company’s revenue streams.

Recent Developments

OptimizeRx has made significant strides in recent years, including:

  • New Product Launches: The company has introduced advanced analytics tools and enhanced patient support services to meet evolving market demands.
  • Strategic Partnerships: OptimizeRx has formed partnerships with leading EHR providers and telehealth platforms to expand its reach and capabilities.
  • Global Expansion: The company has begun exploring opportunities in international markets, aiming to replicate its success in the U.S. on a global scale.
  • COVID-19 Impact: The pandemic accelerated the adoption of digital health solutions, providing a tailwind for OptimizeRx’s business.

Investment Considerations

Strengths:

  • Strong market position and reputation in the digital health space.
  • Comprehensive suite of services that address key healthcare challenges.
  • Robust financial performance and revenue growth.
  • Focus on innovation and strategic partnerships.

Risks:

  • Dependence on pharmaceutical companies for revenue.
  • Exposure to regulatory and compliance risks.
  • Competition from other digital health companies.
  • Potential impact of economic downturns on healthcare spending.

Conclusion

OptimizeRx Corporation is well-positioned to capitalize on the growing demand for digital health solutions. With a strong focus on innovation, strategic partnerships, and market expansion, the company is poised for continued growth. While it faces challenges such as regulatory risks and competition, its comprehensive suite of services and commitment to improving healthcare outcomes make it a compelling player in the digital health space. Investors should weigh the company’s strengths and risks carefully when considering it as a potential investment opportunity.